Header Logo

Connection

Lacey McNally to Female

Back to Details
This is a "connection" page, showing publications Lacey McNally has written about Female.
Lacey McNally
Connection Strength
0.843
Female
  1. Simultaneous Detection of Multiple Tumor-targeted Gold Nanoparticles in HER2-Positive Breast Tumors Using Optoacoustic Imaging. Radiol Imaging Cancer. 2023 05; 5(3):e220180.
    View in: PubMed
    Score: 0.068
  2. Differential expression of microRNA between triple negative breast cancer patients of African American and European American descent. Biotech Histochem. 2022 Jan; 97(1):1-10.
    View in: PubMed
    Score: 0.062
  3. Active Targeting Significantly Outperforms Nanoparticle Size in Facilitating Tumor-Specific Uptake in Orthotopic Pancreatic Cancer. ACS Appl Mater Interfaces. 2021 Oct 27; 13(42):49614-49630.
    View in: PubMed
    Score: 0.061
  4. Diabetes, Obesity, and Inflammation: Impact on Clinical and Radiographic Features of Breast Cancer. Int J Mol Sci. 2021 Mar 09; 22(5).
    View in: PubMed
    Score: 0.059
  5. A New Approach for Automated Image Segmentation of Organs at Risk in Cervical Cancer. Radiol Imaging Cancer. 2020 03; 2(2):e204010.
    View in: PubMed
    Score: 0.055
  6. Osteopontin-targeted probe detects orthotopic breast cancers using optoacoustic imaging. Biotech Histochem. 2018; 93(8):608-614.
    View in: PubMed
    Score: 0.050
  7. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials. 2018 11; 182:114-126.
    View in: PubMed
    Score: 0.049
  8. Detection of microspheres in vivo using multispectral optoacoustic tomography. Biotech Histochem. 2017; 92(1):1-6.
    View in: PubMed
    Score: 0.044
  9. Identification of pancreatic tumors in vivo with ligand-targeted, pH responsive mesoporous silica nanoparticles by multispectral optoacoustic tomography. J Control Release. 2016 06 10; 231:60-7.
    View in: PubMed
    Score: 0.041
  10. Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography. J Nanobiotechnology. 2015 Dec 01; 13:90.
    View in: PubMed
    Score: 0.041
  11. Targeting Acidity in Pancreatic Adenocarcinoma: Multispectral Optoacoustic Tomography Detects pH-Low Insertion Peptide Probes In Vivo. Clin Cancer Res. 2015 Oct 15; 21(20):4576-85.
    View in: PubMed
    Score: 0.040
  12. Orthotopic pancreatic tumors detected by optoacoustic tomography using Syndecan-1. J Surg Res. 2015 Jan; 193(1):246-54.
    View in: PubMed
    Score: 0.038
  13. Targeting of BRAF resistant melanoma via extracellular matrix metalloproteinase inducer receptor. J Surg Res. 2014 Jul; 190(1):111-8.
    View in: PubMed
    Score: 0.036
  14. Chemoresistance in ovarian cancer linked to expression of microRNAs. Biotech Histochem. 2013 Oct; 88(7):403-9.
    View in: PubMed
    Score: 0.034
  15. Lung resistance-related protein (LRP) expression in malignant ascitic cells as a prognostic marker for advanced ovarian serous carcinoma. Ann Surg Oncol. 2013 Sep; 20(9):3059-65.
    View in: PubMed
    Score: 0.034
  16. Therapy of head and neck squamous cell carcinoma with replicative adenovirus expressing tissue inhibitor of metalloproteinase-2 and chemoradiation. Cancer Gene Ther. 2009 Mar; 16(3):246-55.
    View in: PubMed
    Score: 0.025
  17. 18F-FLT PET and Blood-based Biomarkers for Identifying Gastrointestinal Graft versus Host Disease after Allogeneic Cell Transplantation. Radiol Imaging Cancer. 2025 Jan; 7(1):e240096.
    View in: PubMed
    Score: 0.019
  18. An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer. EBioMedicine. 2021 Mar; 65:103271.
    View in: PubMed
    Score: 0.015
  19. Improved pentamethine cyanine nanosensors for optoacoustic imaging of pancreatic cancer. Sci Rep. 2021 02 23; 11(1):4366.
    View in: PubMed
    Score: 0.015
  20. Incidence and Survival by Human Epidermal Growth Factor Receptor 2 Status in Young Women With Stage I-III Breast Cancer: SEER, 2010-2016. Clin Breast Cancer. 2020 08; 20(4):e410-e422.
    View in: PubMed
    Score: 0.014
  21. Predictive modeling of in vivo response to gemcitabine in pancreatic cancer. PLoS Comput Biol. 2013; 9(9):e1003231.
    View in: PubMed
    Score: 0.009
  22. Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model. Gynecol Oncol. 2011 Apr; 121(1):193-9.
    View in: PubMed
    Score: 0.007
  23. Noninvasive monitoring of mRFP1- and mCherry-labeled oncolytic adenoviruses in an orthotopic breast cancer model by spectral imaging. Mol Imaging. 2010 Apr; 9(2):59-75.
    View in: PubMed
    Score: 0.007
  24. Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancer. Clin Cancer Res. 2009 Jun 15; 15(12):4058-65.
    View in: PubMed
    Score: 0.007
  25. In vivo efficacy of marimastat and chemoradiation in head and neck cancer xenografts. ORL J Otorhinolaryngol Relat Spec. 2009; 71(1):1-5.
    View in: PubMed
    Score: 0.006
  26. Early therapy evaluation of combined anti-death receptor 5 antibody and gemcitabine in orthotopic pancreatic tumor xenografts by diffusion-weighted magnetic resonance imaging. Cancer Res. 2008 Oct 15; 68(20):8369-76.
    View in: PubMed
    Score: 0.006
  27. Lymphoid hyperplasia and malignant lymphoma occurring in the ocular adnexa (orbit, conjunctiva, and eyelids): a prospective multiparametric analysis of 108 cases during 1977 to 1987. Hum Pathol. 1990 Sep; 21(9):959-73.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.